This guideline covers diagnosing and managing varicose veins in people aged 18 and over.
The FDA has approved the VenaSeal closure system (VenaSeal system) from Covidien, to permanently treat varicose veins of the legs...
Results from VANISH-2, the first of two US pivotal Phase III trials of Varisolve (polidocanol endovenous microfoam), from BTG, for...
VANISH-2, the first of two US Phase III studies comparing Varisolve (polidocanol endovenous microfilm) from BTG with placebo in patients...
Covidien plc announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial terms of the...
Aethoxysklerol is indicated for sclerotherapy of varicose veins of the lower extremities.
BTG plc announced that the FDA has approved Varithena (polidocanol injectable foam) for the treatment of patients with incompetent veins...
Data from VANISH-1 and VANISH-2, the two US pivotal Phase III trials of Varisolve (polidocanol endovenous microfoam), from BTG, show...